drugset / Trial / NCT06360120

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

NCT06360120

Phase 3 Recruiting 600 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever large-vessel ischemic stroke patients treated with clopidogrel assessed through NIHSS, mRS, and possible adverse effects.

Timeline

Start
2024-04-10
Primary completion
2025-09-10
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg Oral
Comparator Rosuvastatin Small molecule 20 mg
Comparator Clopidogrel Small molecule 75 mg Oral

Indications